15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 21.5% per year over the past 5 years.
Operating margin has expanded, at -9.6% in the latest year.
Financial health
Total debt has grown slower than revenue (-22.4% vs 21.5% per year).
The company is unprofitable; at its current free-cash-flow burn it has roughly 2.0 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$59M
-$4M
40.6%
-9.6%
-$12M
—
$25M
2024
$66M
$33M
49.1%
15.2%
$1M
—
$49M
2023
$65M
$15M
50.4%
20.6%
$9M
—
$30M
2022
$51M
$9M
46.6%
15.3%
$1M
—
$31M
2021
$17M
-$2M
36.3%
-25.2%
-$3M
$2M
$5M
2020
$22M
-$3M
37.6%
-12.4%
-$2M
$2M
$5M
2019
$21M
-$5M
36.1%
-23.7%
-$6M
$0
$5M
2018
$30M
$528000
41.9%
3.1%
-$2M
$0
$17M
2017
$19M
-$6M
35.9%
-26.1%
-$5M
$6M
$18M
2016
—
-$7M
—
—
-$7M
$6M
$939000
2015
—
-$7M
—
—
-$2M
$4M
$6M
2014
—
$422000
—
—
-$946000
$0
$2M
2013
—
-$3M
—
—
-$437000
—
$2M
2012
—
-$3M
—
—
-$5M
—
$2M
2011
—
-$3M
—
—
-$4M
—
$4M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Feb '26
$10M
-$3M
32.7%
-41.0%
-$4M
—
$37M
Nov '25
$10M
-$3M
25.7%
-47.0%
-$2M
—
$31M
Aug '25
$11M
-$2M
33.9%
-37.1%
-$2M
—
$23M
May '25
$14M
-$3M
30.3%
-22.7%
-$5M
—
$25M
Feb '25
$18M
-$643000
39.2%
-6.1%
-$3M
—
$29M
Nov '24
$13M
-$1M
40.1%
-11.2%
-$6M
—
$32M
Aug '24
—
$660000
—
—
—
—
—
Aug '24
$13M
$660000
54.0%
1.2%
$2M
—
$38M
May '24
$17M
$24M
50.9%
15.3%
$1M
—
$49M
Feb '24
$8M
-$1M
41.7%
-27.1%
-$3M
—
$48M
Feb '24
—
-$1M
—
—
—
—
—
Nov '23
$21M
$6M
51.1%
25.5%
-$701000
—
$51M
Aug '23
$21M
$5M
48.4%
20.0%
$4M
—
$51M
Aug '23
$21M
—
0.0%
0.0%
—
—
—
May '23
$22M
$6M
51.5%
25.3%
$5M
—
$30M
Feb '23
$17M
$4M
51.6%
22.0%
-$1M
—
$17M
Nov '22
$15M
$4M
53.4%
23.5%
-$210000
—
$19M
Aug '22
$11M
$589000
42.0%
4.3%
$5M
—
$36M
May '22
$20M
$6M
51.6%
28.7%
-$965000
—
$31M
Feb '22
$15M
$2M
41.9%
14.8%
-$3M
—
$32M
Valuation over time
How the market has priced AEHR against its own fundamentals since 2023-03 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has fallen from 103.4× (Mar '23) to 8.1× (Apr '25).
The price-to-sales ratio has risen from 19.2× (Mar '23) to 52.7× (Jun '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Frequently asked questions
Is AEHR growing its revenue and profit?
Over the past 5 years, Aehr Test Systems's revenue has grown 21.5% per year. These are computed facts, not advice.
How much debt does AEHR have?
As of FY2025, Aehr Test Systems reported — of total debt against $25M of cash.
What is AEHR's profit margin?
In FY2025, gross margin was 40.6%, operating margin -9.6%, and net margin -6.6%.
What is AEHR's P/E ratio?
As of Jun '26, Aehr Test Systems traded at a price-to-earnings ratio of about 8.1× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.